DCF — OCHSNER MEDICAL CENTER - BATON ROUGE
Enterprise Value: $-666.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-666.5M
Enterprise Value
$-209.7M
PV of Cash Flows
$-456.8M
PV of Terminal Value
$-735.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $382.5M | $-42.2M | -11.0% | $-58.3M | $-53.0M |
| Year 2 | $394.0M | $-39.5M | -10.0% | $-56.2M | $-46.4M |
| Year 3 | $405.8M | $-36.6M | -9.0% | $-53.8M | $-40.4M |
| Year 4 | $418.0M | $-35.6M | -9.0% | $-53.3M | $-36.4M |
| Year 5 | $430.5M | $-35.6M | -8.0% | $-53.8M | $-33.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-666.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$371.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11520250115394533
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5